Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Schwartz
    Schwartz
  2. Scher
    Scher
  3. Capanu
    Capanu
  4. Chou
    Chou
  5. Ginsberg
    Ginsberg
  6. Morris
    Morris
  7. Motzer
    Motzer
  8. Russo
    Russo
  9. Shia
    Shia
  10. Carlo
    Carlo

Groups

  1. Body Imaging Service (18)
  2. Department of Medicine (18)
  3. Radiology, Department of (18)
  4. Solid Tumor Oncology Division (18)
  5. Genitourinary Oncology Service (13)
  6. GSK Faculty (8)
  7. Biostatistics Service (6)
  8. Epidemiology and Biostatistics (6)
  9. Hematologic Malignancies, Division of (6)
  10. Surgery (6)
Search Within
  1. "Body Imaging Service"
  2. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (17)
  2. Research Letter (1)
Groups
  1. Body Imaging Service (18)
  2. Department of Medicine (18)
  3. Radiology, Department of (18)
  4. Solid Tumor Oncology Division (18)
  5. Genitourinary Oncology Service (13)
  6. GSK Faculty (8)

More Groups

People
  1. Lawrence Schwartz (6)
  2. Howard Scher (5)
  3. Jinru Shia (3)
  4. Joanne Chou (3)
  5. Marinela Capanu (3)
  6. Michael Morris (3)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Lancet Oncology (4)
  2. European Urology (3)
  3. Urology (3)
  4. Journal of Urology (2)
  5. Magnetic Resonance Imaging (2)
  6. Annals of Thoracic Surgery (1)

More Publications

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy for metastatic clear cell renal cell carcinoma in patients treated with first-line immunotherapy combinations
    Research Letter

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy
    Journal Article

    Carlo, M. I.; Attalla, K.; Mazaheri, Y.; Gupta, S.; Yildirim, O.; Murray, S. J.; Coskey, D. T.; Kotecha, R.; Lee, C. H.; Feldman, D. R.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • CT radiomic features for predicting resectability and TNM staging in thymic epithelial tumors
    Journal Article

    Araujo-Filho, J. A. B.; Mayoral, M.; Zheng, J.; Tan, K. S.; Gibbs, P.; Shepherd, A. F.; Rimner, A.; Simone, C. B. 2nd; Riely, G.; Huang, J.; more...
    Annals of Thoracic Surgery (2022)

    Fulltext@MSK | Save
  • The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: A simulation-based analysis
    Journal Article

    Ward, Z. J.; Atun, R.; Hricak, H.; Asante, K.; McGinty, G.; Sutton, E. J.; Norton, L.; Scott, A. M.; Shulman, L. N.
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Malignant priapism in metastatic prostate cancer: A late event occurring early
    Journal Article

    Barrett-Campbell, O.; Petkovska, I.; Slovin, S. F.
    Urology Case Reports (2018)

    Fulltext@MSK | Save
  • Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: Ablation with clear margins (A0) provides the best local tumor control
    Journal Article

    Shady, W.; Petre, E. N.; Do, K. G.; Gonen, M.; Yarmohammadi, H.; Brown, K. T.; Kemeny, N. E.; D'Angelica, M.; Kingham, P. T.; Solomon, S. B.; more...
    Journal of Vascular and Interventional Radiology (2018)

    Fulltext@MSK | Save
  • Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy
    Journal Article

    Robertson, N. L.; Sala, E.; Benz, M.; Landa, J.; Scardino, P.; Scher, H. I.; Hricak, H.; Vargas, H. A.
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save